MW Neumora Therapeutics shares plunge as depression treatment misses trial targets
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 02, 2025 10:48 ET (15:48 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.